Seegene tirelessly pursues innovation and takes on new challenges to build a better future for humanity.
With the development of proprietary high multiplex real-time PCR technologies,
Seegene has produced and delivered molecular diagnostics (MDx) products capable of detecting multiple targets simultaneously.
Seegene’s products identify and provide a wide range of clinical information integral to diagnosis and care, enabling healthcare
professionals to select the best treatment in the early stages of disease.
Also, by opening a new paradigm of diagnostics in medicine/healthcare,
Seegene is playing a vital role in safeguarding humanity from diseases and allowing individuals to lead a healthy life.